Disease control and prevention vaccine market
Disease Control and Prevention Vaccine Market - by Product Type (Live-Attenuated, Inactivated, Recombinant Sub Unit and Toxoid), by Type (Monovalent and Multivalent), By Route of Administration (Oral and Injectable), by Age Group (Pediatric Vaccine and Adult Vaccine), and By Indication (Infectious Disease, Cancer and Other Indications) - Global Forecast to 2025
- Apr 2018
- CMI1500
- 210 Pages
- Excel & Pdf
- Pharmaceutical
Disease Control and Prevention Vaccine Market – Insights
Vaccines are biological entity used to activate acquired immunity to control or prevent particular disease or a group of disease. Immunization is carried out in infants as well as in adults. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control world-wide. According to European Centre for Disease Prevention and Control (ECDC), pertussis and invasive pneumococcal disease account for over 50% of vaccine preventable disease and over 60% of deaths. The completion immunization schedule from infant to adulthood significantly reduces burden of vaccine preventable disease. According to World Health Organization (WHO), 2018 factsheet, immunization prevents 2 to 3 million deaths annually. Furthermore, around 1.5 million deaths can be prevented by improving vaccine coverage. Several vaccine manufacturers’ work in partnership with civil society organization such as World Health Organization (WHO), United Nations Children's Fund (UNICEF), and Global Alliance for Vaccines and Immunisation (GAVI) Alliance to improve their vaccination program for reducing number of patient suffering from diseases
The global disease control and prevention vaccine market was valued at US$ 41.12 billion in 2017 and is expected to witness a CAGR of 12.1 % over the forecast period (2017–2025).
Global Disease Control and Prevention Vaccine Market, By Product Type
Source: Coherent Market Insights Analysis (2018)
High Prevalence of Infectious Disease is Expected to Drive Growth of the Disease Control and Prevention Vaccine Market
High prevalence and increasing incidence of infectious disease are the major factors driving growth of the disease control and prevention vaccine market. According to the study published in journal Lancet Infectious Disease, around 54,984,661 cases of 45 infectious diseases were reported with average yearly incidence 417·98 per 100?000 in china between January 2004 and December 2013. Furthermore, Hepatitis B and tuberculosis has high incidence rate of 81.57 and 80.33 per 100,000, respectively. Moreover, World Health Organization (WHO) estimated 212 million malaria cases globally in 2015 with highest incidence in African regions.
Furthermore, the vaccines manufactured by novel technologies such as recombinant technology or cell-based vaccine production is decreasing the gap between demand and supply, which is expected to drive growth of the disease control and prevention vaccine market. For instance, in 2013, Protein Science Corporation received FDA approval for Flubok Trivalent Vaccine, produced by recombinant technology in the U.S. Moreover, in 2016, Seqirus received US FDA approval for Flucelvax Quadrivalent, cell-culture derived influenza vaccine.
Increasing Governmental Initiatives for Immunization Programs is Driving Growth of the Disease Control and Prevention Vaccine Market
Governmental and non-governmental organization partners are working together to provide better immunization to population for complete disease eradication. For instance, the Global Polio Eradication Initiative was a public-private partnership between five governmental agencies - the World Health Organization (WHO), Rotary International, the US Centers for Disease Control and Prevention (CDC), the United Nations Children’s Fund (UNICEF) and the Bill & Melinda Gates Foundation, aiming at polio eradication worldwide. The program was funded US$ 15 billion in the period 1988 - 2017, provided by public and private donors and 2013 - 2019 requirement was projected to US$ 7 billion. Furthermore, organization such as Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH) have partnered with the U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) to support development of advanced influenza vaccines. Such governmental approaches are expected to augment the growth of global disease control and prevention vaccine market over the forecast period (2017-2025). However, high cost of vaccine development is expected to restrain growth of the disease control and prevention vaccine market.
According to Access to Medicine Foundation index, 2017, vaccine market is dominated by four major players, collectively referred as 'big four': GSK, Merck & Co., Inc., Pfizer, and Sanofi. Big four contribute to 80% of the global vaccine revenue. Players vary significantly by portfolio and pipeline size. Other major players operating in market include AstraZeneca PLC, Sinovac Biotech Ltd., Astellas Pharma Inc., Serum Institute of India Pvt. Ltd., and Daiichi Sankyo.
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Type
- Market Snippet, By Route of Administration
- Market Snippet, By Age Group
- Market Snippet, By Indication
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Governmental Initiative
- Product Pipeline
- Regulatory Landscape
- PEST Analysis
- PORTER’S Five Forces
- Global Disease Control and Prevention Vaccines Market, By Product Type, 2015–2025, (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Live-attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Inactivated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Global Disease Control and Prevention Vaccines Market, By Type, 2015–2025, (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Monovalent Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Multivalent Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Global Disease Control and Prevention Vaccines Market, By Route of Administration, 2015–2025, (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Global Disease Control and Prevention Vaccines Market, By Age Group, 2015–2025, (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Pediatric Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Adult Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Global Disease Control and Prevention Vaccines Market, By Indication, 2015–2025, (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Other Indications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Global Disease Control and Prevention Vaccines Market, By Regions, 2015–2025, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2017 and 2025 (%)
- Y-o-Y Growth Analysis, By Region, 2015–2025
- Regional Trends
- North America
- U.S.
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Canada
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Europe
- U.K.
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Germany
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Italy
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- France
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Spain
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Russia
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Rest of Europe
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Asia Pacific
- China
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Japan
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- India
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- ASEAN
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Australia
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- South Korea
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Rest of Asia Pacific
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Latin America
- Brazil
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Mexico
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Rest of Latin America
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Africa
- Northern Africa
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Central Africa
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- South Africa
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Middle East
- GCC Countries
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Israel
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Rest of Middle East
- Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
- Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
- Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- GlaxoSmithKline plc (GSK)
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Merck & Co. Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Sanofi
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- AstraZeneca PLC
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Serum Institute of India Pvt. Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Sinovac Biotech Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Astellas Pharma Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Daiichi Sankyo
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Analyst Views
- Section
- References
- Research Methodology
- About Us and Sales Contact
*Browse 47 market data tables and 45 figures on "Disease Control and Prevention Vaccines Market - Global forecast to 2025”.